Xantos Biomedicine AG has approved funding from the Bavarian Ministry of Economy
In addition the project will aim at expanding the use of the OPERA System (Evotec Technologies), a high content screening tool, which is based on confocal microscopy, broadening the range of assays to be performed significantly. In addition to that further assays will be implemented to monitor the induced cellular phenotypes with complex intracellular biology. The second goal of this project will be to improve the access to Qiagen's RNAi libraries and implementing these libraries in various novel assays and optimizing this tool in combination with the traditional overexpression approach. As announced earlier this year Xantos has signed a comarketing agreement with Qiagen. The project and grants received will allow Xantos a highly competitive positioning of its service platform.
Most read news
Topics
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.